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The ﬁrst deﬁnitive blood cells during embryogenesis are derived from endothelial cells in
a highly conserved process known as endothelial-to-haematopoietic transition (EHT).
This conversion involves activation of a haematopoietic transcriptional programme in a
subset of endothelial cells in the major vasculature of the embryo, followed by major mor-
phological changes that result in transitioning cells rounding up, breaking the tight junc-
tions to neighbouring endothelial cells and adopting a haematopoietic fate. The whole
process is co-ordinated by a complex interplay of key transcription factors and signalling
pathways, with additional input from surrounding tissues. Diverse model systems, includ-
ing mouse, chick and zebraﬁsh embryos as well as differentiation of pluripotent cells in
vitro, have contributed to the elucidation of the details of the EHT, which was greatly
accelerated in recent years by sophisticated live imaging techniques and advances in
transcriptional proﬁling, such as single-cell RNA-Seq. A detailed knowledge of these
developmental events is required in order to be able to apply it to the generation of
haematopoietic stem cells from pluripotent stem cells in vitro — an achievement which is
of obvious clinical importance. The aim of this review is to summarise the latest ﬁndings
and describe how these may have contributed towards achieving this goal.
Introduction
In vertebrate animals, a close relationship exists between haematopoietic cells and endothelial cells.
Haematopoietic cells travel through endothelium-lined blood vessels; they migrate in and out of the
blood stream via docking to and transversing the endothelial layer; and haematopoietic stem and pro-
genitor cells (HSPCs) are regulated and maintained by a vascular niche in the bone marrow during
adult life and in the foetal liver during foetal life [1–3]. However, the relationship could not be any
more intimate than during the generation of the ﬁrst deﬁnitive HSPCs since these are directly pro-
duced from endothelial precursors in a process termed endothelial-to-haematopoietic transition
(EHT). This cell fate transition involves switching on a haematopoietic transcriptional programme in
select endothelial cells, which then become haemogenic, followed by considerable morphological
changes that lead to the breaking of tight junctions with neighbouring endothelial cells and rounding
up, to then being released into the blood stream (Figure 1).
The ontogeny of the haematopoietic system is characterised by multiple waves, multiple origins and
shifting locations. The murine yolk sac gives rise to an initial wave of primitive erythroid cells, starting
from embryonic day (E) 7.5, inside structures known as yolk sac blood islands, which consist of the
ﬁrst population of endothelial cells surrounding the newly formed primitive blood cells. The simultan-
eous appearance of blood and endothelial cells from a seemingly homogeneous cluster of mesodermal
precursors initially led to the theory that primitive haematopoiesis did not originate from haemogenic
endothelial cells (HECs), but from a developmentally earlier precursor termed haemangioblast, which
displayed clonal bipotentiality for blood and endothelium and which had been detected in vitro [4]
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and in vivo [5]. More recent studies, however, have questioned the existence of such a bipotential precursor and
have instead suggested that primitive blood may also derive from HECs located in the yolk sac [6,7].
In contrast with primitive haematopoiesis, deﬁnitive blood emerges in the context of a fully formed and
functional vascular system. This again initiates in the yolk sac with the appearance of erythroid-myeloid pro-
genitors (EMPs) by E8.5 [8] and immune-restricted progenitors [9]: two progenitor types that seem to comple-
ment each other with their differentiation potential. Adult-type haematopoietic stem cells (HSCs) that can fully
repopulate the haematopoietic system of irradiated adult recipients upon direct transfer are not detected until
E10.5. They ﬁrst emerge in the dorsal aorta within the aorta-gonads-mesonephros (AGM) region and its asso-
ciated major vessels, the umbilical and vitelline arteries [10–12]. Subsequently, they are also detected in the
yolk sac, the placenta and the embryonic head, before they go on to colonise the foetal liver [13–15]. In each
case, HSCs are found in the major vasculature within these tissues; however, it is not clear whether they are
formed de novo in all of these tissues and whether a similar process of EHT is taking place. For example, even
though embryonic head endothelial cells were shown to give rise to blood cells that contribute to the adult
haematopoietic system [14], endothelium-associated haematopoietic cell clusters, which are signs of active EHT,
have never been observed in the head [16].
Because of its importance as the ﬁrst site of HSC generation, the process of EHT and its underlying molecu-
lar mechanisms have been almost exclusively studied in the dorsal aorta, which is what this review will there-
fore also concentrate on. Many excellent reviews on the haemogenic endothelium have been published in
recent years [17–19], which this review will aim to provide an update on.
First experimental evidence
The concept of an endothelial origin for deﬁnitive blood is not new. Histological observations made already 100
years ago proposed the existence of haemogenic endothelium [20–22]; however, experimental support came
much later, initially in birds, but then also in mice. Using the avian system, which allows ex vivo manipulations,
in this case, dye-labelling of endothelial cells prior to haematopoietic development, Jaffredo, Dieterlen-Lièvre
and colleagues were able to demonstrate that the label was subsequently passed on to emerging blood cells [23].
Ten years later, temporally restricted genetic labelling allowed similar fate mapping in mice, which conﬁrmed
that endothelial cells gave rise to emerging blood cells in the dorsal aorta which then went on to colonise the
foetal liver and the adult bone marrow, where they contributed to haematopoiesis long-term [24].
Advances in live imaging have allowed real-time observation of EHT [25–28]. Zebraﬁsh embryos, which are
transparent and develop externally, lend themselves particularly well to such observational studies. Stunning
movies from the Herbomel lab of live zebraﬁsh embryos revealed how endothelial cells with a ﬂat morphology
initiate EHT by rounding up, pulling neighbouring endothelial cells towards each other and eventually pinching
off as round haematopoietic cells that are released into the circulation [28].
How these images can be reconciled with intra-aortic cluster formation is currently unknown. Marker
expression analysis in mouse embryos suggests that emerging blood cells undergo further maturation within
these clusters as they lose endothelial properties and up-regulate a haematopoietic programme. Indeed, an
Figure 1. Stepwise formation of HSPCs from endothelial cells.
Depicted are the morphological events thought to take place in the dorsal aorta of the mouse embryo during the formation of HSPCs. Up-regulation
of a haematopoietic transcriptional programme in endothelial cells during the speciﬁcation of HECs is marked by a light red colour. EHT is
characterised by a shape change towards a rounder cell with further implementation of a haematopoietic programme and breaking of tight junctions
with neighbouring endothelial cells. HECs giving rise to pro-HSCs and pre-HSCs is thought to result in the formation of intra-aortic clusters in which
cells mature into haematopoietic stem and progenitor cells as they colonise the foetal liver.
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elegant explant culture system developed in the Medvinsky lab was able to dissect EHT into intermediate steps
[29–31]. HECs were shown to mature into fully functional HSCs via a pro-HSC, pre-HSC I and pre-HSC II
stage, which was accompanied by sequential up-regulation of the cell surface markers CD41, CD43 and CD45.
Recreating EHT in vitro
A long-term goal, which could be considered the Holy Grail of the ﬁeld due to its obvious clinical signiﬁcance,
is the generation of fully functional HSCs from pluripotent stem cells (PSCs) in vitro. While robust protocols
exist for the differentiation of mouse and human PSCs [embryonic stem cells/induced PSCs (iPSCs)] into
deﬁnitive haematopoietic cells, it is thought that these recapitulate the processes taking place in the early yolk
sac and do not lead to the generation of HSCs. Indeed, differentiation of PSCs into considerable numbers of
HSCs that are capable of long-term, high-level, multi-lineage haematopoietic reconstitution upon direct trans-
plantation has proven to be a major challenge, although signiﬁcant advances have been made recently [32,33].
What has become clear from the many attempts is the need for a thorough understanding of how HSCs are
generated in vivo during embryogenesis, which has sparked renewed interest into the properties of HECs and
the inner workings of the EHT (recently reviewed in refs. [34–36]). In fact, the PSC differentiation system with
its accessibility and ease for manipulation has greatly contributed to our increased knowledge of the molecular
details of the EHT.
Another approach for generating HSCs via recreating EHT in vitro that has shown great promise is the
induction of a haemogenic programme in adult endothelial cells cultured within a vascular niche, which
resulted in the production of HSCs with high-level, multi-lineage engraftment potential [37]. This study high-
lighted the fact that endothelial cells not only act as direct precursors of HSCs but are also components of the
niche that supports the generation and maintenance of HSCs.
Transcription factors—complexes, levels and dynamics
Conversion of PSCs or adult ECs into HSCs has relied on the ectopic expression of key transcription factors
that drive the endothelial-to-haematopoietic conversion by suppressing the endothelial transcriptional pro-
gramme and instead switching on haematopoietic genes (Figure 2). Two key transcription factors that have
been shown to be absolutely required for the generation of HSCs from HECs in vivo are Runx1 [28,38–40] and
Gata2 [41–44]. Due to the technical difﬁculties associated with low cell numbers in developing embryos, little
is currently known about the complexes and networks that these two transcription factors function in, although
it was previously reported that two downstream targets of Runx1, the transcriptional repressors Gﬁ1 and Gﬁ1b,
are also essential for successful completion of the EHT through repression of the endothelial programme via
the recruitment of Kdm1a [45]. It is also known that the activity of Runx1 is absolutely dependent on the pres-
ence of the cofactor Cbfβ, with the knockout of Cbfb displaying an almost identical phenotype to Runx1
knockout embryos [46,47].
Considering the importance of Runx1 and Gata2 in the EHT, it may not come as a surprise that the timing
and the levels of their expression need to be tightly controlled. Early indications came from studies showing
that haploinsufﬁciency of Runx1 led to a temporal and spatial shift in HSC appearance [48], while half a dose
Figure 2. The regulation of EHT.
Key transcription factors involved in the EHT are shown in red and key signalling pathways in green. Cell surface markers characteristic for each
stage are shown in purple. Whether a gene is up-regulated or down-regulated during the process is highlighted by its position above or below the
schematic, respectively.
© 2019 The Author(s). This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). 593
Biochemical Society Transactions (2019) 47 591–601
https://doi.org/10.1042/BST20180320
of Gata2 resulted in reduced production of HSCs speciﬁcally in the AGM region [43]. Furthermore, it has been
reported that HECs express lower levels of Runx1 than are expressed by haematopoietic progenitors [49].
Two Runx1 isoforms have been detected, with the Runx1b isoform being controlled by the proximal pro-
moter P2, while the expression of the Runx1c isoform is under the control of the distal promoter P1. P2, and
thus Runx1b, activity initiates earlier, during the initial stages of the EHT, while P1/Runx1c are activated later
during the EHT and in already committed haematopoietic progenitors and remain more prominent in the
adult haematopoietic system [50,51]. In addition, it was recently demonstrated, using the PSC system, that
Runx1b levels need to be kept low for initiation and successful completion of the EHT, since increased levels of
Runx1b accelerate the onset of EHT, but are unable to drive haematopoietic maturation [52].
Increased expression of Runx1 was also detected in embryos deﬁcient for the Notch1 target genes Hes1 and
Hes5 [53]. Despite these embryos containing larger intra-aortic clusters and increased numbers of phenotypic
haematopoietic progenitors in the AGM, these were non-functional, and haematopoietic development was
severely impaired. In this case, however, the authors linked the haematopoietic defect to a failure to down-
regulate Gata2, which is normally repressed by Hes1. This study demonstrated that Gata2 levels also need to be
tightly and temporally regulated, as a Notch1-induced Gata2 expression spike is essential for haematopoietic
development, but sustained Gata2 expression renders haematopoietic progenitors non-functional.
Even though Notch1 signalling is required to initiate expression of important haematopoietic regulators such
as Gata2, its activity also needs to be restricted to allow for the completion of the EHT, as high Notch activity
promotes an arterial programme in endothelial cells, while suppressing the haematopoietic programme [54]. In
fact, a reporter system that differentially labels cells with high or low Notch activity has identiﬁed two popula-
tions in the dorsal aorta, an arterial-restricted population with high Notch activity and a haematopoietic-
competent population with low Notch activity [55]. That same study further revealed the involvement of two
different Notch ligands, with Dll4 inducing high Notch activity and thus implementing the arterial programme,
while Jag1 facilitated the haematopoietic programme by restricting Notch activity. A down-regulation of Notch
signalling was also observed during the maturation of pre-HSCs into fully competent HSCs [56].
Another transcriptional regulator with a function analogous to Notch is Sox17. It is known to determine
arterial fate [57], but also to specify HECs [58]. Like Notch, it promotes the endothelial programme over the
haematopoietic programme and needs to be down-regulated for the EHT to proceed [54]. It was found to be
co-expressed with Runx1 in HECs and has been suggested to repress Runx1 function [54,58,59]. Indeed, rela-
tive levels of Runx1 and Sox17 as determined by measuring the ratio of their mean ﬂuorescence intensities by
immunoﬂuorescence microscopy and correlating this with morphological changes detected by scanning elec-
tron microscopy can identify cells at the different stages of EHT [59]. Flat and elongated endothelial cells that
are ﬁrmly integrated into the endothelial layer had a very low Runx1:Sox17 ratio, whereas cells inside the
intra-aortic clusters scored with a high Runx1:Sox17 ratio. Thus, the levels of Runx1 and Sox17 are negatively
correlated, with an increasing ratio of Runx1:Sox17 associated with the adoption of a haematopoietic fate.
Interestingly, this was also associated with the appearance of membrane protrusions, the signiﬁcance of which
needs to be determined.
Very recently, Gata2 levels during the EHT were reported to be highly dynamic as measured with the help of
a short-lived ﬂuorescent Venus reporter for Gata2 expression [60]. Not only were different levels of
Gata2-Venus detected among endothelial cells and intra-aortic cluster cells, but the expression of the reporter
in these cells demonstrated a highly dynamic and pulsatile nature that could be correlated with different stages
along the EHT. Speciﬁcally, cells that were emerging from the endothelium to form intra-aortic clusters dis-
played a shorter periodicity of Gata2-Venus expression pulses than HECs, thus demonstrating a higher
dynamic nature. In addition, cells rounding up at the initiation of the EHT also demonstrated higher pulse
amplitudes. The signiﬁcance of these Gata2 expression pulses is currently unknown, although a functional role
is suggested by an alteration in pulsatile behaviour in Gata2 heterozygous embryos that have reduced haemato-
poietic activity.
RNA modiﬁcations—another level of regulation
A new mode of transcriptional control that has received a lot of attention lately and also has an impact on
haematopoietic cell generation in the AGM involves RNA modiﬁcations. The most common RNA modiﬁcation
in eukaryotes is the creation of N6-methyl-adenosine, which is laid down by RNA-speciﬁc methyltransferases,
such as Mettl3 [61,62]. These modiﬁcations are recognised by speciﬁc reader proteins, which then target these
RNA molecules for further processing, such as splicing, or degradation. Mettl3 was found to be expressed in
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endothelial cells, including HECs, and haematopoietic cells in both zebraﬁsh and mouse embryos [63].
Furthermore, morpholino-mediated knock-down of mettl3 in zebraﬁsh embryos resulted in decreased runx1
and cmyb expression and reduced numbers of HECs and HSPCs, which were further impaired in their haem-
atopoietic differentiation. Interestingly, vascular development was normal, but endothelial cells maintained
their endothelial identity and could not undergo the EHT. This was to a large part due to increased levels of
Notch pathway components, whose mRNAs are normally targets of mettl3 and become N6-methylated at the
time of EHT. Morpholino targeting of the N6-methyl-adenosine reader ythdf2, which targets methylated
mRNAs for degradation, resulted in a similar phenotype and demonstrated that down-regulation of Notch
activity for completion of EHT is, at least in part, achieved by modulation and degradation of notch1a mRNA
via mettl3 and ythdf2. This pathway is conserved in mice [63,64].
Notch activity is also down-regulated by Gpr183 signalling-mediated ubiquitination and degradation of the
Notch1 protein [65].
Molecular details of EHT
Despite having known about the existence of EHT in the generation of HSPCs for a considerable amount of
time and having identiﬁed some of the key transcriptional regulators and signalling pathways, knowledge of the
molecular details, especially the morphological changes and restructuring involved, is still very much limited.
Many transcriptional proﬁling studies on non-HECs, HECs, cells undergoing EHT, intra-aortic cluster cells and
HSPCs, some even at the single-cell level, have been performed in recent years with the aim of shedding more
light on this process [49,66–71] (Table 1).
One of the ﬁrst proﬁling studies of the EHT took advantage of the previously identiﬁed Runx1 + 23 enhan-
cer, which is active in deﬁnitive HSPCs and HECs and, when linked to a GFP reporter, serves as an excellent
tool for the isolation of these populations [49,50,72]. Through a combination of expression analyses and func-
tional assays, it was established that HECs gradually lose their endothelial identity between E8.5 and E10.5 as
their haematopoietic potential increases, with clonogenic assays indicating that endothelial and haematopoietic
capacities are mutually exclusive [49]. The initiation of the haematopoietic programme in endothelial cells des-
tined to become HECs is co-ordinated by Runx1 and the rapid decline of Runx1 expression in endothelial cells
after E10.5 points to a very transient nature of HECs.
Other studies have focused on one or two developmental time points and compared the different cell popu-
lations from non-HEC to HSPCs with the aim of identifying, and ordering along a differentiation trajectory,
the intermediate cellular states with the accompanying transcriptional stages. The identiﬁcation of additional
cell surface markers [69,71] and the use of further ﬂuorescent reporter mouse lines [66,68,70] have made these
isolation strategies ever more sophisticated.
Using a combination of markers for endothelial cells (CD31), intra-aortic cluster cells (ckit) and HECs/
HSPCs (Ly6a-GFP), non-HECs, HECs, HSCs and more mature haematopoietic cells were compared, which led
to the identiﬁcation of the G protein-coupled receptor Gpr56 as being up-regulated concomitant with the onset
of the haematopoietic programme, with functional studies in zebraﬁsh conﬁrming a role for Gpr56 in HSC
emergence [70]. This study also reported an up-regulation of genes in HECs associated with migration, Notch
pathway activation and hypoxia. Indeed, the same group had previously described a role for the
hypoxia-induced gene Hif1a in HSC development [73]. Interestingly, a cell cycle signature was not detected
until the HSC state, suggesting that cell proliferation occurs after completion of haematopoietic differentiation
[70].
Using the same Ly6a-GFP reporter line, but in combination with CD31, Cdh5, Esam and ckit, another
group compared GFP+ and GFP− endothelial cells and intra-aortic cluster cells [68]. They described a striking
up-regulation of inﬂammatory pathways in HECs that was not triggered by an infection. Speciﬁcally, they
found that interferon signalling increased HSPC production. This novel role of sterile pro-inﬂammatory signals
promoting HSPC emergence from HECs was also discovered by two other groups using the zebraﬁsh system
[67,74], who reported that TNFα produced by primitive neutrophils initiated an inﬂammatory response in
HEC via Tnfr2 and the TLR4–MyD88–NFκB axis, with the Notch pathway being an important downstream
target. The activation of this cascade was required for the speciﬁcation of haematopoietic cells from HECs.
The advent of single-cell RNA-Seq has allowed a more detailed dissection of the differentiation pathway
from endothelial cell to haematopoietic cell [66,69,71]. Additional intermediate cellular states have been uncov-
ered that can be ordered along a differentiation trajectory using pseudotime algorithms, which is most promin-
ently marked by a gradual down-regulation of endothelial-speciﬁc genes and an up-regulation of
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haematopoietic genes. Zhou et al. described EPCR as a cell surface marker up-regulated as endothelial cells dif-
ferentiate into pre-HSCs [71], with another group describing a further enrichment for pre-HSCs through the
combination of EPCR with Dll4 [75]. This differential expression of EPCR between endothelial cells and
pre-HSCs allowed Zhou et al. to isolate and sequence single endothelial cells, type I and II pre-HSCs and foetal
liver HSCs [71]. They noticed the biggest transcriptional change taking place during the transition from endo-
thelial cell to pre-HSC, with a general increase in transcriptional activity in pre-HSCs, which included genes
involved in mitochondrial aerobic respiration, in the mTOR pathway and also inﬂammation-related genes. In
addition, a high degree of heterogeneity in cell cycle status in the pre-HSC population was observed. Indeed, it
was recently described that intra-aortic cluster cells at an earlier maturation stage, located at the base of the
cluster, are more quiescent than more mature cells found at the tip of the cluster which are more actively
cycling [76]. This suggests an expansion of pre-HSCs prior to their colonisation of the foetal liver and matur-
ation into HSCs. The same authors have subsequently mined their data sets speciﬁcally for long non-coding
Table 1 Phenotype of cell populations analysed by transcriptional profiling
Cell
population Phenotype Stage Profiling Reference
Non-HECs
HECs
HSPCs
Runx1 + 23GFP−Cdh5+Ter119−CD45−CD41−
Runx1 + 23GFP+Cdh5+Ter119−CD45−CD41−
Runx1 + 23GFP+Cdh5+Ter119−CD45−CD41+
E8.5, E9.25,
E10.5
Microarrays and
scqRT-PCR
[49]
Non-HECs
HECs
HSCs
HPCs
Ly6a-GFP−CD31+ckit−
Ly6a-GFP+CD31+ckit−
Ly6a-GFP+CD31+ckit+
Ly6a-GFP−CD31+ckit+
E10.5 Bulk RNA-Seq [70]
GFP+ ECs
GFP− ECs
GFP+ HCCs
GFP− HCCs
Ly6a-GFP+CD31+Cdh5+Esam+ckit−
Ly6a-GFP−CD31+Cdh5+Esam+ckit−
Ly6a-GFP+CD31+Cdh5+Esam+ckit+
Ly6a-GFP−CD31+Cdh5+Esam+ckit+
E10.5 Bulk RNA-Seq [68]
Trunk HECs
Trunk rest
runx1-GFP+
runx1-GFP−
26–28 hpf Bulk RNA-Seq [67]
ECs
Pre-HSC I
Pre-HSC II
HSC (FL)
HSC (FL)
CD31+Cdh5+CD41−CD43−CD45−Ter119−
CD31+CD45−CD41locKit+EPCRhi
CD31+CD45+CD41lo
Lin−Sca1+Mac1loEPCR+
CD45+CD150+CD48−EPCR+
E11.5
E11.5
E11.5
E12
E14
10-cell and scRNA-Seq [71]
HCCs
Non-HECs
HECs
EHT cells
Pre-HSC I
Pre-HSC II
HSPCs (YS)
ckit+
Cdh5+Gfi1-tomato−Gfi1b-GFP−ckit−
Cdh5+Gfi1-tomato+Gfi1b-GFP−ckit−
Cdh5+Gfi1-tomato+Gfi1b-GFP−ckit+
Cdh5+ckit+CD45−
Cdh5+ckit+CD45+
ckit+
E11.5
E10/E11
E11
E10/E11
scRNA-Seq [66]
ECs-HSPCs
Non-HECs
HECs
Pre-HSPC I
Pre-HSPC II
Pro-HSCs
Pre-HSC I
Pre-HSC II
Non-HECs
HECs
Pre-HSPC I
Pre-HSPC II
Cdh5+
Cdh5+CD44−
Cdh5+CD44lockit−
Cdh5+CD44lockit+
Cdh5+CD44hi
Cdh5+CD41+CD43−CD45−
Cdh5+CD41+CD43+CD45−
Cdh5+CD41+CD43+CD45+
Cdh5+CD44−
Cdh5+CD44lockit−
Cdh5+CD44lockit+
Cdh5+CD44hi
E10.5
E10
E10
E9.5/10/11
E9.5/10
E11
scRNA-Seq
scqRT-PCR
scqRT-PCR
Bulk RNA-Seq
[69]
Abbreviations: EC, endothelial cell; EHT, endothelial-to-haematopoietic transition; FL, foetal liver; HEC, haemogenic endothelial cell; HCC,
haematopoietic cluster cell; HPC, haematopoietic progenitor cell; hpf, hours post fertilisation; HSC, haematopoietic stem cell; HSPC, haematopoietic
stem/progenitor cell; sc, single cell; YS, yolk sac.
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RNAs and detected an up-regulation of H19 at the pre-HSC stage. An endothelial-speciﬁc knockout of the dif-
ferentially methylated region that controls H19 expression led to severely impaired EHT and formation of
HSPCs. Mechanistically, H19 was shown to regulate promoter methylation of key EHT transcription factors,
such as Runx1, with increased methylation in its absence causing a down-regulation of Runx1 [77].
Single-cell RNA-Seq proﬁling by Baron et al. also highlighted that the greatest number of transcriptional
changes takes place during the EHT, while there were only few genes differentially expressed during the transi-
tion from a non-HEC to an HEC [66]. The authors also carried out a careful analysis of the composition of the
intra-aortic clusters and found these to contain type I and type II pre-HSCs as well as more committed HSPCs.
This study has sequenced the most comprehensive repertoire of cell populations from endothelial cells to
HSPCs to date. With gene sets specifying each step having been identiﬁed, this should serve as an important
resource.
In the most recent single-cell RNA-Seq study, CD44 was identiﬁed as a marker that becomes detectable spe-
ciﬁcally in the transitioning population in which endothelial and haematopoietic programmes are co-expressed.
Its levels further increase with the onset of ckit expression and mark cells that undergo morphological changes
during the EHT. In fact, together with ckit and Cdh5, CD44 allowed an accurate isolation of cell stages from
non-HEC to mature HSPCs. Furthermore, CD44 appears to have a functional role, as a disruption of the inter-
action with its ligand hyaluronan interfered with the EHT. It was further noted that compared with non-HEC,
HECs were less proliferative and displayed a lower metabolic activity, but exhibited an increase in the expres-
sion of genes linked to lipid biosynthesis, Notch pathway activation and autophagy. An exit from the cell cycle
may be necessary for a cell to undergo the EHT.
EHT vs. epithelial-to-mesenchymal transition
On the surface, EHT seems to share similarities with another major cell fate change — the
epithelial-to-mesenchymal transition (EMT), and it was this obvious analogy that led to the adoption of the
term EHT. Like EHT, EMT plays an essential role during development in tissue morphogenesis, but it is also a
process involved in metastasis, when tumour cells gain the ability to leave their tissue-of-origin and seed other
sites in the body. It is interesting in this context that it was recently reported that homophilic interactions of
CD44 on breast cancer cells enhance the formation of clusters of these cells, which leads to increased metastatic
potential [78]. It should be investigated whether CD44 may also be important for intra-aortic cluster formation
during EHT and what the functional signiﬁcance of this may be.
Another pathway that is shared by the EMT and EHT is Tgfb signalling [37,79–83]. Activation of the Tgfb
pathway was shown to promote the EMT, while its role in the EHT has been seemingly controversial. While
some reports suggested that activation of Tgfb signalling promotes the EHT [81,82], others suggested that Tgfb
activity needs to be down-regulated for the EHT to proceed [37,80,83]. While some of the controversies may be
explained by the suggestion that the compound SB431542, commonly employed as an inhibitor of the Tgfb
pathway [37,83], may have a more complex mode of action and can in fact increase phosphorylation and acti-
vation of Smad2/3 [82], which are downstream effectors of Tgfb signalling, other reports suggest that Tgfb sig-
nalling, like Notch activation, is essential for the speciﬁcation of HECs, but may have to be down-regulated for
the EHT to proceed [80]. In this context, the role of HDAC1 may also need further clariﬁcation. It is clear that
it is required for HSPC speciﬁcation from endothelial cells; however, in one study, it was reported to act by
modulating the Tgfb pathway and Smad2/3 [82], while another group found it to activate Smad1/5, which led
to ERK inhibition and the promotion of the haematopoietic programme [84]. A similar controversy surrounds
the related Bmp signalling pathway, which may also have to be down-regulated during the ﬁnal stages of HSPC
formation [85].
Remaining questions
Our understanding of the details of the EHT has increased substantially in recent years (Figure 2), aided by the
development of more sophisticated proﬁling and analysis tools. Despite this increase in knowledge, routine and
efﬁcient generation of HSCs from PSCs has still not been achieved although recent progress is promising. What
are we still missing?
The more we learn about the process of HSPC speciﬁcation, the more complex it turns out to be with many
unanswered questions remaining. Haematopoietic progenitor generation from PSCs is much more successful,
so how does it differ from producing HSCs? The embryo generates both stem and progenitor cells from HEC,
but the former is a much rarer event, and we do not currently know how these two processes differ and why
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an HEC in one case may give rise to a stem cell, while in other cases, a more mature progenitor is produced.
There is also evidence that there are different types of HECs [86], and that the process of the EHT may not be
the same in every haematopoietic tissue [16]. Related to this is the question of how HECs are speciﬁed in the
ﬁrst place. While grafting experiments in avian embryos suggested a spatial segregation of haemogenic and
non-haemogenic-fated endothelial precursors early on in development [87], it was more recently suggested that
all nascent endothelial cells are competent to become HECs [49].
Even though there is very good evidence from endothelial fate mapping and endothelial-speciﬁc knockout
studies (described above) that HSCs are generated from HECs, it could nevertheless be speculated that HSCs
are in fact generated via a different mechanism—one that has so far not been recreated in the PSC system.
Some of the markers that are employed for endothelial-speciﬁc targeting, such as Cdh5, continue to be
expressed on HSCs, and temporal control of expression in vivo can be challenging [88]. Some staining results
suggest that HSC precursors may also be located in the sub-aortic mesenchyme [30], and a knockout of Runx1
resulted in the accumulation of Runx1-LacZ+ cells in the sub-endothelial layer [89]. Whether these HSC
precursors, upon maturation to HSCs, directly traverse the endothelial layer, temporarily integrate into the
endothelial layer or adopt an endothelial fate before undergoing EHT, requires further investigation.
We also know relatively little about the surrounding supportive cells that make up the microenvironment
and how they promote the EHT. It is clear that there is something special about the AGM microenvironment
that allows HSC speciﬁcation to occur in this part of the vasculature so efﬁciently. We are slowly starting to
learn more about these AGM-derived supportive signals [90,91].
It is also clear that a simple activation of key transcription factors is not sufﬁcient, but that the timing,
co-expression, levels and dynamics need to be precisely controlled. These are all challenges that may have to be
overcome before we can rely on a patient-speciﬁc supply of in vitro-generated HSCs for the clinic.
Perspectives
• The EHT is the process through which haematopoietic stem and progenitor cells are ﬁrst generated during
development. A deciphering of the details would allow blood generation from pluripotent stem cells in vitro
for cell replacement therapies.
• Several of the key transcription factors and signalling pathways driving EHT have been identiﬁed.
Intermediate cellular and transcriptional states are being elucidated through novel ex vivo culture systems
and expression proﬁling.
• More insight into the timing, relative levels and dynamics of key transcription factor expression as well as
the contribution of the microenvironment need to be gained before robust generation of haematopoietic
stem cells in vitro can be achieved.
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